Urology
Volume 75, Issue 4 , Pages 779-785 , April 2010

Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer: Effects Modified by Plasma Antioxidants

  • Jianjun Zhang

      Affiliations

    • Department of Public Health, Indiana University School of Medicine, Indianapolis, Indiana
    • Department of Epidemiology, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • Corresponding Author InformationReprint requests: Jianjun Zhang, M.D., Ph.D., Department of Public Health, Indiana University School of Medicine, 714 N Senate Ave, Suite EF250, Indianapolis, IN 46202
    • ,
  • Ishwori B. Dhakal

      Affiliations

    • Department of Epidemiology, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Graham Greene

      Affiliations

    • Department of Urology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Nicholas P. Lang

      Affiliations

    • Department of Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
    • ,
  • Fred F. Kadlubar

      Affiliations

    • Department of Epidemiology, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Received 11 March 2009 ,Accepted 26 August 2009.

References 

  1. Parkin DM. International variation. Oncogene. 2004;23:6329–6340
  2. Bostwick DG, Alexander EE, Singh R, et al. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer. 2000;89:123–134
  3. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate. 1997;32:229–233
  4. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005;23:8152–8160
  5. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155:1985–1992
  6. Roberts RO, Bergstralh EJ, Bass SE, et al. Prostatitis as a risk factor for prostate cancer. Epidemiology. 2004;15:93–99
  7. Willett WC. Nutritional Epidemiology. New York, NY: Oxford University Press; 1998;
  8. Zhang J, Dhakal I, Stone A, et al. Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas. Nutr Cancer. 2007;59:46–53
  9. Xu J, Zheng SL, Turner A, et al. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res. 2002;62:2253–2257
  10. Chen L, Elahi A, Pow-Sang J, et al. Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol. 2003;170:2471–2474
  11. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–1530
  12. Hirata H, Hinoda Y, Tanaka Y, et al. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer. 2007;43:231–237
  13. Kohno T, Shinmura K, Tosaka M, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–3225
  14. Lunn RM, Langlois RG, Hsieh LL, et al. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–2561
  15. Duell EJ, Wiencke JK, Cheng TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–971
  16. Nam RK, Zhang WW, Jewett MA, et al. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res. 2005;11:8391–8397
  17. Xu Z, Hua LX, Qian LX, et al. XR, Zhang W and Wu HF: relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China. Asian J Androl. 2007;9:331–338
  18. van Gils CH, Bostick RM, Stern MC, et al. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev. 2002;11:1279–1284
  19. Stone A, Ratnasinghe LD, Emerson GL, et al. CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005;14:1257–1261
  20. El-Sohemy A, Baylin A, Kabagambe E, et al. Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr. 2002;76:172–179
  21. Ritchey JD, Huang WY, Chokkalingam AP, et al. Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev. 2005;14:1703–1709
  22. Chen L, Ambrosone CB, Lee J, et al. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol. 2006;175:108–112discussion:112
  23. Rybicki BA, Conti DV, Moreira A, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:23–29
  24. Dherin C, Radicella JP, Dizdaroglu M, et al. Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res. 1999;27:4001–4007
  25. Janssen K, Schlink K, Gotte W, et al. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat Res. 2001;486:207–216
  26. Goodman M, Bostick RM, Ward KC, et al. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype. Nutr Cancer. 2006;55:13–20
  27. Wallace TA, Prueitt RL, Yi M, et al. Tumor immunobiological differences in prostate cancer between African-American and European–American men. Cancer Res. 2008;68:927–936
  28. Bogen KT, Keating GA. U.S. dietary exposures to heterocyclic amines. J Expo Anal Environ Epidemiol. 2001;11:155–168
  29. Tang D, Liu JJ, Bock CH, et al. Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate. Int J Cancer. 2007;121:1319–1324
  30. Hughes C, Murphy A, Martin C, et al. Molecular pathology of prostate cancer. J Clin Pathol. 2005;58:673–684
  31. Comstock GW, Alberg AJ, Helzlsouer KJ. Reported effects of long-term freezer storage on concentrations of retinol, beta-carotene, and alpha-tocopherol in serum or plasma summarized. Clin Chem. 1993;39:1075–1078

 This study is supported by grants from the Centers for Disease Control and Prevention through the Arkansas Comprehensive Cancer Control Program (116-1005406, Dr. Zhang, PI) and from the National Institute on Aging, NIH (1R01AG15722, Dr. Lang, PI).

PII: S0090-4295(09)02505-9

doi: 10.1016/j.urology.2009.08.063

Urology
Volume 75, Issue 4 , Pages 779-785 , April 2010

Article Tools